Pelthos Therapeutics to acquire Castle Creek Biosciences in gene therapy merger backed by $57.5m financing
Read More General business news Bridgewest Ventures raises NZ$60.2m as New Zealand deep tech attracts offshore capital New Zealand deep tech is undercapitalised. Bridgewest Ventures’ NZ$60.2m fund raise shows why offshore investors are circling. byPallavi MadhirajuMay 24, 2026